Mechanisms of Etomidate-Mediated Decrease of Spontaneous Spike Activity of Mouse Cerebellar Purkinje Cells in vivo

Abstract

Etomidate is an imidazole, nonbarbiturate hypnotic agent that is increasingly used in procedural sedation. However, the effects of etomidate on the spontaneous activity of cerebellar Purkinje cells (PCs) in living mouse have not been fully understood. In this study, we investigated the effects of etomidate on the spontaneous simple spike (SS) activity of PCs in urethane-anesthetized mice by cell-attached recording and pharmacological methods. Cerebellar surface application of etomidate (50 μmol\\L) reduced the SS firing rate in a concentration-dependent manner (IC50: 43.4 µmol\\L). Application of either a γ-aminobutyric acid type A (GABA_A) receptor antagonist, SR95531 (20 μmol\\L) or a glycine receptor antagonist strychnine (10 μmol\\L) significantly attenuated but not abolished the etomidate-induced decrease in PC SS firing rate. However, co-application of SR95531 (20 μmol\\L) and strychnine (10 μmol\\L) abolished the etomidate-induced decrease in PC SS firing rate. Moreover, intraperitoneal injection of etomidate (3 mg/kg body weight) also induced a significant depression in PC SS firing rate, which was blocked by the co-application of SR95531 and strychnine on the cerebellar surface. These results indicate that both GABA_A and glycine receptors are involved in the etomidate-induced decrease in PC SS firing rate in vivo in mice.